Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Walker

Showing results (311-320 of 568) with videos related to

Pageof 57
Sort By:
The Lancet. Psychiatry|April 18, 2025
Priorities for addressing mental health conditions and substance use disorders in prisons in sub-Saharan Africa: expert consensus from a Delphi panelHelen E Jack, Aish Lovett, Hiwot Weldemariam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2018
Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized TrialJennifer A Thompson, Cissy Kityo, David Dunn, et al.
Plos One|November 7, 2013
The immunological and virological consequences of planned treatment interruptions in children with HIV infectionNigel Klein, Delali Sefe, Ilaria Mosconi, et al.
Wellcome Open Research|August 26, 2024
A Phase I trial of Non-invasive Ventilation and seizure prophylaxis with levetiracetam In Children with Cerebral Malaria Trial (NOVICE-M Trial)Kathryn Maitland, Nchafasto Obonyo, Mainga Hamaluba, et al.
Science (New York, N.Y.)|April 6, 2019
The challenge of antimicrobial resistance: What economics can contributeLaurence S J Roope, Richard D Smith, Koen B Pouwels, et al.
Applied and Environmental Microbiology|September 12, 2020
Risk Factors Associated with Carbapenemase-Producing <i>Enterobacterales</i> (CPE) Positivity in the Hospital Wastewater EnvironmentStacy C Park, Hardik Parikh, Kasi Vegesana, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2013
Whole-genome sequencing shows that patient-to-patient transmission rarely accounts for acquisition of Staphylococcus aureus in an intensive care unitJames R Price, Tanya Golubchik, Kevin Cole, et al.
Brain : a Journal of Neurology|October 1, 2010
Magnetization transfer ratio may be a surrogate of spongiform change in human prion diseasesDurrenajaf Siddique, Harpreet Hyare, Stephen Wroe, et al.
Communications Medicine|October 10, 2024
Predicting future hospital antimicrobial resistance prevalence using machine learningKarina-Doris Vihta, Emma Pritchard, Koen B Pouwels, et al.
Antiviral Therapy|December 15, 2010
Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW TrialVictor Musiime, Lindsay Kendall, Sabrina Bakeera-Kitaka, et al.
Pageof 57

Showing results (311-320 of 568) with videos related to

Sort By:
Pageof 57
The Lancet. Psychiatry|April 18, 2025
Priorities for addressing mental health conditions and substance use disorders in prisons in sub-Saharan Africa: expert consensus from a Delphi panelHelen E Jack, Aish Lovett, Hiwot Weldemariam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2018
Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized TrialJennifer A Thompson, Cissy Kityo, David Dunn, et al.
Plos One|November 7, 2013
The immunological and virological consequences of planned treatment interruptions in children with HIV infectionNigel Klein, Delali Sefe, Ilaria Mosconi, et al.
Wellcome Open Research|August 26, 2024
A Phase I trial of Non-invasive Ventilation and seizure prophylaxis with levetiracetam In Children with Cerebral Malaria Trial (NOVICE-M Trial)Kathryn Maitland, Nchafasto Obonyo, Mainga Hamaluba, et al.
Science (New York, N.Y.)|April 6, 2019
The challenge of antimicrobial resistance: What economics can contributeLaurence S J Roope, Richard D Smith, Koen B Pouwels, et al.
Applied and Environmental Microbiology|September 12, 2020
Risk Factors Associated with Carbapenemase-Producing <i>Enterobacterales</i> (CPE) Positivity in the Hospital Wastewater EnvironmentStacy C Park, Hardik Parikh, Kasi Vegesana, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 17, 2013
Whole-genome sequencing shows that patient-to-patient transmission rarely accounts for acquisition of Staphylococcus aureus in an intensive care unitJames R Price, Tanya Golubchik, Kevin Cole, et al.
Brain : a Journal of Neurology|October 1, 2010
Magnetization transfer ratio may be a surrogate of spongiform change in human prion diseasesDurrenajaf Siddique, Harpreet Hyare, Stephen Wroe, et al.
Communications Medicine|October 10, 2024
Predicting future hospital antimicrobial resistance prevalence using machine learningKarina-Doris Vihta, Emma Pritchard, Koen B Pouwels, et al.
Antiviral Therapy|December 15, 2010
Pharmacokinetics and acceptability of once- versus twice-daily lamivudine and abacavir in HIV type-1-infected Ugandan children in the ARROW TrialVictor Musiime, Lindsay Kendall, Sabrina Bakeera-Kitaka, et al.
Pageof 57